Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Astrocytoma 8Glioblastoma 5Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Recurrence 3Prostatic Neoplasms 3Lung Neoplasms 3Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neurofibroma 1Neuroblastoma 1

Interventions

Temozolomide 16Magnetic Resonance Spectroscopy 10Etoposide 9Cyclophosphamide 8Radiotherapy 7Carboplatin 7Bevacizumab 7Filgrastim 6Thiotepa 5Radiation 4Biopsy 4Azacitidine 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4sargramostim 3etoposide phosphate 3Surveys and Questionnaires 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Methotrexate 3Irinotecan 3Gadolinium DTPA 3Cisplatin 3Automobiles 3lutetium Lu 177 dotatate 2fluorodopa F 18 2alovudine 2aldesleukin 2Yoga 2Topotecan 2Thalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ependymoma × antineoplaston AS 2-1 × Clear all
NCT00003479 2022-02-23

Antineoplaston Therapy in Treating Patients With Ependymoma

Burzynski Research Institute

Phase 2 Terminated
9 enrolled 6 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡